R3D-72531-68020
2 vaccinations
4 coded responses
19 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 029 / RI
- Registered
- 2021-07-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-16
Registered in v-safe
-
2021-07-16
Dose 1 — Pfizer-BioNTech
-
2021-07-16
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-07-17
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-07-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-07-19
- 2021-07-20
- 2021-07-21
- 2021-07-22
- 2021-07-23
- 2021-08-01
-
2021-08-06
Survey response — day 21, dose 1MedDRA: Headache — Feeling: GoodFree text: Off and on headaches, basically daily, since getting my first dose.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-13
Dose 2 — Pfizer-BioNTech
- 2021-08-13
- 2021-08-20
- 2021-08-27
- 2021-09-03
-
2021-09-10
Survey response — day 28, dose 2MedDRA: Migraine — Feeling: Good · Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
- 2021-09-17
- 2021-09-24
-
2021-11-14
Survey response — 3 months, dose 2MedDRA: Exposure to SARS-CoV-2, Malaise — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Close contact to a COVID case. Now also experiencing symptoms. Getting a rapid and PCR today.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-14
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-16
-
2022-02-13
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Contracted COVID for the second time. Once on 12/26 and again on 1/26MedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-16 | Pfizer-BioNTech | No |
| 2 | 2021-08-13 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 9 — day 21, dose 1
Symptoms: Off and on headaches, basically daily, since getting my first dose.
Release 9 — day 28, dose 2
Symptoms: Migraine
Release 10 — 3 months, dose 2
Symptoms: Close contact to a COVID case. Now also experiencing symptoms. Getting a rapid and PCR today.
Release 11 — 6 months, dose 2
Symptoms: Contracted COVID for the second time. Once on 12/26 and again on 1/26
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release